Using Coronary Artery Calcium Score in the Quest for Cardiac Health. Robert J. Hage, D.O.

Size: px
Start display at page:

Download "Using Coronary Artery Calcium Score in the Quest for Cardiac Health. Robert J. Hage, D.O."

Transcription

1 Using Coronary Artery Calcium Score in the Quest for Cardiac Health Robert J. Hage, D.O.

2 Heart disease is the leading cause of death in the United States in both men and women. About 610,000 people die of heart disease in the United States every year that s 1 in every 4 deaths. Coronary heart disease is the most common type of heart disease, killing over 370,000 people annually. Every year about 735,000 Americans have a heart attack. Of these, 525,000 are a first heart attack and 210,000 happen in people who have already had a heart attack. 01 / Write Your Title Here 02 / Write Your Title Here

3 Atherosclerosis begins with damage to the endothelium, a thin layer of cells that line the arteries. The body responds to the damage with the formation of plaque, a combination of low density lipoproteins, White blood cells, and other substances. This leads to arterial stiffening, narrowing, and thrombolysis.

4 Risk Factors High blood pressure High blood cholesterol Diabetes and prediabetes Smoking Being overweight or obese Being physically inactive Having a family history of early heart disease Having a history of preeclampsia during pregnancy Unhealthy diet Age These have been known for decades, but heart diseas remains rampant.

5

6 How To Live a Healthy Lifestyle? A healthy diet leads to a lower Body Mass Index. And maintaining a normal BP is important in limiting the progression of atherosclerosis

7 About Our CT Study A low dose multislice CT scanner can perform a cardiac scan in 5-10 minutes.

8 Radiation Dose Comparisons Source of Radiation Chest x-ray Mammogram Effective Radiation Dose 0.05 msv 0.7 msv Source: Harvard Heart Letter, Published July 2012 Calcium scoring test Annual Natural exposure 3 msv Cardiac catheterization 7 msv Chest CT 10 msv Coronary CT angiography 3-14 msv Radionuclide sestamibi stress test msv Radionuclide dual isotope myocardial perfusion imaging 25 msv

9 Risk: Incidental Findings CT's can demonstrate incidental findings, which can lead to further tests and radiation exposure, frequently with a benign diagnosis. In this case, however, the patient had a CT-guided needle biopsy, which showed small cell carcinoma.

10 CAD Pathology Soft plaque appears as blood on the CT scan and is not visualized. The advanced calcified plaque is well seen and can be quantified.

11 Coronary Arteries Cardiac gating allows finely detailed views of many of the anatomical structures of the heart. 01 / Write Your Title Here 02 / Write Your Title Here

12 CT Scan Agatston The semiautomatic Agatston scoring software calculates the product of the calcified plaque area within a CT slice and incorporates a plaque-specific density factor of 1, 2, 3, or 4. The density factor reflects increasing categories of Hounsfield units (Hu). Thus, the Agatston score is weighted upward for greater CAC density..

13 Agatston Score Table 01 / Write Your Title Here 02 / Write Your Title Here

14 Coronary Artery Calcification Slide Patient A

15 Coronary Artery Calcification Slide Patient B

16 Coronary Artery Calcification Slide Patient C 61 year old male PM Hx: Hypertension, Hypercholesterolemia 15 yr. smoking history, quit in 2001 Fam Hx: Coronary artery disease 2017 Agatston score = 1, Agatson score = 15.6

17 Framingham Cardiac Risk Score Standard Framingham Cardiovascular Disease Risk Prediction Using BMI Gender Age Systolic BP Treatment for HTN? Current smoker? Diabetes mellitus? Body Mass Index(BMI) Using Lipids Gender Age Systolic BP Treatment for HTN? Current smoker? Diabetes mellitus? HDL Total Cholesterol

18 Framingham Risk Classification Algorithm Risk Classification Algorithm Used in the ATP-III 2004 Update Risk Category High Risk Moderately high risk Moderate risk Lower risk Definition CHD or CHD risk equivalent or >2 risk factors and 10-y predicted risk of >20% >2 Risk factors and 10-y predicted risk of 10% to 20% >2 Risk factors and 10-y predicted risk of <10% 0-1 Risk factor

19 Framingham Risk Score Graph Source:

20 Arterial Age as a Function of Coronary Artery Calcium (From themulti-ethnic Study of Atherosclerosis [MESA]) Contributors: Robyn L. McClelland, PhDa, Khurram Nasir, MD MPHb, Matthew Budoff, MDc, Roger S. Blumenthal, MDd, and Richard A. Kronmal, PhDa Table 1: Estimated Arterial Age and 95% Confidence Intervals by Coronary Arterial Age CA CA in Years Arterial Age in Years (95% CI) C C (95% CI) 0 39 (32 46) (71 74) (53 60) (75 80) (59 63) (78 83) (62 66) (79 86) (65 67) (80 88) (67 69) (83 92) (68 70) (69 71) (70 72) (71 73) 0 Position here Position here 89 (84 94) 92 (87 98) 94 (88 100) 96 (89 102) osition here Position here Estimated Arterial Age and 95% Confidence Bands by Coronary Artery Calcium The estimated arterial age with 95% confidence bands is displayed for each CAC score. CAC is displayed on the log scale, but labeled in original units for ease of use. A person with a CAC score of 10 Agatston units has an estimated arterial age of approximately 56, while a CAC score of 400 yields an arterial age of 83. Discussion Point Using arterial age when calculating the Framingham risk is more predictive of short-term incident coronary events. Also, it gives patients an understandable interpretation of their CAC score.

21 Coronary Artery Calcium Testing Among Statin Candidates Viewpoint Approximately 45 million American adults who have been diagnosed with cardiovascular disease are recommended to be considered for statin therapy, based on the ACC/AHA recommendations for individuals with 10 year ASVD risks of 7.5% and 5% to 7.5%. Of these 45 million patients, nearly 50% will have a CAC of zero. The Kaplan-Meier curves demonstrates significantly reduced estimated cardiac events in this group. This supports reducing their risk and possibly obviating the need for statin therapy.

22 Discrimination of MESA 01 / Write Your Title Here 02 / Write Your Title Here McClelland, R, et. al, Journal of American College of Cardiology, Vol 66, Nov 15, 2015

23 Follow-up cardiac scan A follow-up Cardiac Scan was performed after approximately 3 years. The progression is visually striking. Markedly advanced atherosclerotic calcifications are noted in the left anterior descending 01 coronary / Write Your artery. Title Here The total Agatston score has increased 02 / Write from Your 470 Title to a Here current value of 821.

24 Follow-up cardiac scan # 2 These images demonstrate the significant calcified atherosclerotic progression in the proximal circumflex artery. 01 / Write Your Title Here 02 / Write Your Title Here

25 After 3 years, the patient s Agatston score increased from 36.5 to 67.0 with mild plaque burden.

26 The patient complained of chest pain for two weeks. His Agatston score was 2,442. He was sent to the emergency room for evaluation.

27 The asymptomatic patient had a score of 1,583, which placed her in the 96th percentile.

Diagnostic and Prognostic Value of Coronary Ca Score

Diagnostic and Prognostic Value of Coronary Ca Score Diagnostic and Prognostic Value of Coronary Ca Score Dr. Ghormallah Alzahrani Cardiac imaging division, Adult Cardiology department Prince Sultan Cardiac Center ( PSCC) Madina, June 2 Coronary Calcium

More information

Khurram Nasir, MD MPH

Khurram Nasir, MD MPH Non-invasive CAD Screening Khurram Nasir, MD MPH Disclosures I have no relevant commercial relationships to disclose, and my presentation will not include off label or unapproved usage. HOW & WHAT WOULD

More information

Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017

Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017 Coronary Artery Calcification Dharmendra A. Patel, MD MPH Director, Echocardiography Laboratory Associate Program Director Cardiovascular Disease Fellowship Program Erlanger Heart and Lung Institute UT

More information

Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification

Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification Matthew Budoff, MD, FACC, FAHA Professor of Medicine Director, Cardiac CT Harbor-UCLA Medical Center, Torrance, CA

More information

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD 1 Preclinical? No symptoms No physical findings No diagnostic ECG findings No chest X-ray X findings No diagnostic events 2

More information

Coronary Artery Calcium Score

Coronary Artery Calcium Score Coronary Artery Calcium Score August 19, 2014 by Axel F. Sigurdsson MD 174 Comments essential for living organisms. Calcium is a chemical element that is Most of the calcium within the human body is found

More information

Coronary Artery Calcium. Vimal Ramjee, MD FACC The Chattanooga Heart Institute

Coronary Artery Calcium. Vimal Ramjee, MD FACC The Chattanooga Heart Institute Coronary Artery Calcium Vimal Ramjee, MD FACC The Chattanooga Heart Institute Disclosures I have no conflicts of interest to disclose. Objectives Recognize the utility of coronary artery calcium scoring

More information

Cardiac CT Angiography

Cardiac CT Angiography Cardiac CT Angiography Dr James Chafey, Radiologist Why do we need a better test for C.A.D? 1. CAD is the leading cause of death in the US CAD 31% Cancer 23% Stroke 7% 2. The prevalence of atherosclerosis

More information

New Paradigms in Predicting CVD Risk

New Paradigms in Predicting CVD Risk New Paradigms in Predicting CVD Risk Imaging as an Integrator of Lifetime Risk Exposure Michael J. Blaha MD MPH Presented by: Michael J. Blaha September 24, 2014 1 Talk Outline Risk factors vs. Disease

More information

Conceptual Approach to CAD Risk. Disclosures. Integrating Imaging and Biomarkers for Optimal CVD Risk Assessment and Management 2/10/2014.

Conceptual Approach to CAD Risk. Disclosures. Integrating Imaging and Biomarkers for Optimal CVD Risk Assessment and Management 2/10/2014. Integrating Imaging and Biomarkers for Optimal CVD Risk Assessment and Management None Disclosures Arthur Agatston Conceptual Approach to CAD Risk Devereux Circulation, 1993 1 Age Obesity Family Hx Diabetes

More information

Imaging-Guided Statin Allocation: Seeing Is Believing

Imaging-Guided Statin Allocation: Seeing Is Believing Imaging-Guided Statin Allocation: Seeing Is Believing The New Paradigm in Personalized Risk Assessment & Medication Prescribing Presented by: Michael J. Blaha May 15, 2014 1 General Principles of Talk

More information

Dr Chris Ellis. Consultant Cardiologist Auckland

Dr Chris Ellis. Consultant Cardiologist Auckland Dr Chris Ellis Consultant Cardiologist Auckland CVD Risk Prevention in NZ 2013 & Beyond: The Clinicians View Dr Chris Ellis Cardiologist Green Lane CVS Service, Cardiology Department, Auckland City Hospital

More information

Correlation between Coronary Calcium Score and risk of Artery Disease in presence of Conventional Cardiac Risk Factors

Correlation between Coronary Calcium Score and risk of Artery Disease in presence of Conventional Cardiac Risk Factors Purpose: Correlation between Coronary Calcium Score and risk of Artery Disease in presence of Conventional Cardiac Risk Factors Riaz Soomro 1 and Nayyar Jabeen 2 ABSTRACT Purpose of this study is to investigate

More information

Potential recommendations for CT coronary angiography in athletes

Potential recommendations for CT coronary angiography in athletes Potential recommendations for CT coronary angiography in athletes B.K. Velthuis Dept. of Radiology UMC Utrecht, the Netherlands EuroPRevent 15 April 2011 Declaration of interest Philips Medical Systems

More information

Coronary Artery Calcification

Coronary Artery Calcification Coronary Artery Calcification Julianna M. Czum, MD OBJECTIVES CORONARY ARTERY CALCIFICATION Julianna M. Czum, MD Dartmouth-Hitchcock Medical Center 1. To review the clinical significance of coronary heart

More information

Calcium is a chemical element that is essential for living organisms.

Calcium is a chemical element that is essential for living organisms. 1 of 8 9/28/2015 9:04 AM Home About me Health and Nutrition Diet General Health Heart Disease August 19, 2014 By Axel F. Sigurdsson MD 259 Comments Like Share 82 Calcium is a chemical element that is essential

More information

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment

More information

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Quanta Diagnostico Nuclear Curitiba, Brazil Clinical history Male 63 y.o.,

More information

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases Eun-Jung Rhee Department of Endocrinology and Metabolis Kangbuk Samsung Hospital Sungkyunkwan

More information

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive

More information

Coronary Calcium Predicts Events Better With Absolute Calcium Scores Than Age-Sex-Race/Ethnicity Percentiles

Coronary Calcium Predicts Events Better With Absolute Calcium Scores Than Age-Sex-Race/Ethnicity Percentiles Journal of the American College of Cardiology Vol. 53, No. 4, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.07.072

More information

Disclosures CORONARY CALCIUM SCORING REVISITED. Learning Objectives. Scoring Methods. Consultant for M2S, Inc. Coronary Calcium Scoring: Software

Disclosures CORONARY CALCIUM SCORING REVISITED. Learning Objectives. Scoring Methods. Consultant for M2S, Inc. Coronary Calcium Scoring: Software CORONARY CALCIUM SCORING REVISITED Disclosures Consultant for M2S, Inc. Julianna M. Czum, MD Director, Division of Cardiothoracic Imaging Department of Radiology Dartmouth Hitchcock Medical Center Assistant

More information

Coronary Artery Calcium Scoring Mirvat Alasnag FACP, FRCP, FSCCT, FSCAI, FASE King Fahd Armed Forces Hospital, Jeddah. March 2017

Coronary Artery Calcium Scoring Mirvat Alasnag FACP, FRCP, FSCCT, FSCAI, FASE King Fahd Armed Forces Hospital, Jeddah. March 2017 Coronary Artery Calcium Scoring Mirvat Alasnag FACP, FRCP, FSCCT, FSCAI, FASE King Fahd Armed Forces Hospital, Jeddah March 2017 Newspapers Referrals 62 year old female CT chest and abdomen following

More information

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases Eun-Jung Rhee Department of Endocrinology and Metabolism Kangbuk Samsung Hospital Sungkyunkwan

More information

Advanced Imaging MRI and CTA

Advanced Imaging MRI and CTA Advanced Imaging MRI and CTA Who and why may benefit. Matthew W. Martinez, M.D. FACC Lehigh Valley Health Network Director, Cardiovascular Imaging Learning Objectives Review basics of CMR and CTA Review

More information

Lipid Management 2013 Statin Benefit Groups

Lipid Management 2013 Statin Benefit Groups Clinical Integration Steering Committee Clinical Integration Chronic Disease Management Work Group Lipid Management 2013 Statin Benefit Groups Approved by Board Chair Signature Name (Please Print) Date

More information

Is computed tomography angiography really useful in. of coronary artery disease?

Is computed tomography angiography really useful in. of coronary artery disease? Is computed tomography angiography really useful in screening patients with high risk of coronary artery disease? Myeong-Ki Hong, M.D. Ph D Professor of Medicine Division of Cardiology, Severance Cardiovascular

More information

Who Cares About the Past?

Who Cares About the Past? Risk Factors, the New Calcium Score, Rheology and Atherosclerosis Progression Arthur Agatston 2/21/15 The Vulnerable Plaque vs. Plaque Burden CT Angiogram Is There a Role for Coronary Artery Calcium Scoring

More information

Dr Chris Ellis Cardiologist, Auckland City Hospital

Dr Chris Ellis Cardiologist, Auckland City Hospital Dr Chris Ellis Cardiologist, Auckland City Hospital CT Cardiac Angiography: Clinical Use Dr Chris Ellis Cardiologist Greenlane CVS Services Auckland City Hospital & Auckland Heart Group: Mercy Hospital

More information

Dr Sandra Birchem Cardiologist Cardiovascular Division Mayo Clinic Rochester and Mayo Clinic Health System MFMER slide-1

Dr Sandra Birchem Cardiologist Cardiovascular Division Mayo Clinic Rochester and Mayo Clinic Health System MFMER slide-1 Dr Sandra Birchem Cardiologist Cardiovascular Division Mayo Clinic Rochester and Mayo Clinic Health System 2011 MFMER slide-1 Heart Disease in Women and Why we are concerned 6,600,000 US women >440,000

More information

I have no financial disclosures

I have no financial disclosures Manpreet Singh MD I have no financial disclosures Exercise Treadmill Bicycle Functional capacity assessment Well validated prognostic value Ischemic assessment ECG changes ST segments Arrhythmias Hemodynamic

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

Oxford Technology Showcase 2016 Big Healthcare Challenges in chronic disease. Inflammation quantification for cardiovascular risk characterisation

Oxford Technology Showcase 2016 Big Healthcare Challenges in chronic disease. Inflammation quantification for cardiovascular risk characterisation Big Healthcare Challenges in chronic disease Inflammation quantification for cardiovascular risk characterisation Developing an advanced biomarker of Coronary Artery Disease using common CT imaging Dr.

More information

MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING

MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING MEDICAL POLICY PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.

More information

Physical Activity and Coronary calcification ADJ ASSOCIATE PROFESSOR TAN SWEE YAW NATIONAL HEART CENTRE SINGAPORE

Physical Activity and Coronary calcification ADJ ASSOCIATE PROFESSOR TAN SWEE YAW NATIONAL HEART CENTRE SINGAPORE Physical Activity and Coronary calcification ADJ ASSOCIATE PROFESSOR TAN SWEE YAW NATIONAL HEART CENTRE SINGAPORE Calcium Scores (CACS) Calcium Scores (CACS) Calcium Scores are indicative of the presence

More information

CORONARY ARTERY CALCIUM AND INCIDENT STROKE IN THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) COHORT ASHLEIGH A. OWEN, MD

CORONARY ARTERY CALCIUM AND INCIDENT STROKE IN THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) COHORT ASHLEIGH A. OWEN, MD CORONARY ARTERY CALCIUM AND INCIDENT STROKE IN THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) COHORT BY ASHLEIGH A. OWEN, MD A Thesis Submitted to the Graduate Faculty of WAKE FOREST UNIVERSITY GRADUATE

More information

Are Lipids (or Risk Factors) the Optimal Marker for ASCVD Risk Assessment? Time for Paradigm Shift? Franklin D. Roosevelt. Khurram Nasir, MD MPH

Are Lipids (or Risk Factors) the Optimal Marker for ASCVD Risk Assessment? Time for Paradigm Shift? Franklin D. Roosevelt. Khurram Nasir, MD MPH Are Lipids (or Risk Factors) the Optimal Marker for ASCVD Risk Assessment? Time for Paradigm Shift? Khurram Nasir, MD MPH How Cardiovascular Disease Became Our Biggest Threat? 1900-1940: Infectious diseases

More information

David Ramenofsky, MD Bryan Kestenbaum, MD

David Ramenofsky, MD Bryan Kestenbaum, MD Association of Serum Phosphate Concentration with Vascular Calcification in Patients Free of Chronic Kidney Disease: The Multi Ethnic Study of Atherosclerosis David Ramenofsky, MD Bryan Kestenbaum, MD

More information

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA CT Imaging of Atherosclerotic Plaque William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA PREVALENCE OF CARDIOVASCULAR DISEASE In 2006 there were 80 million

More information

NEW GUIDELINES FOR CHOLESTEROL

NEW GUIDELINES FOR CHOLESTEROL NEW GUIDELINES FOR CHOLESTEROL NEW CHOLESTEROL GUIDELINES 2013 Recently updated guidelines for the treatment of high blood cholesterol levels is a major update since 2002. The news media have trumpeted

More information

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This

More information

CT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong

CT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong CT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong Promises, Pitfalls and Hard Truths of Coronary Calcium Scanning Selwyn Wong Ascot and Middlemore Hospitals Coronary Calcium Scoring

More information

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida The 21 st Century Paradigm Shift: Prevention Rather Than Intervention for the Treatment of Stable CHD The Economic Burden of Cardiovascular Diseases Basil Margolis MD, FACC, FRCP Director, Preventive Cardiology

More information

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute Which Test When? Avoid the Stress of Stress Testing Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute Outline Understand the importance of coronary artery disease assessment Understand the basics

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease

More information

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital Coronary Artery Imaging Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital Larger array : cover scan area Detector size : spatial resolution Rotation speed : scan time Retrospective

More information

ACC/AHA GUIDELINES ON LIPIDS AND PCSK9 INHIBITORS

ACC/AHA GUIDELINES ON LIPIDS AND PCSK9 INHIBITORS ACC/AHA GUIDELINES ON LIPIDS AND PCSK9 INHIBITORS Ziyad Ghazzal MD, FACC, FSCAI Professor of Medicine Deputy Vice President/Dean Associate Dean for Clinical Affairs American University of Beirut Adjunct

More information

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,

More information

Short and Long Term Prognosis after Coronary Artery Calcium Scoring

Short and Long Term Prognosis after Coronary Artery Calcium Scoring Short and Long Term Prognosis after Coronary Artery Calcium Scoring In Pre-Elderly and Elderly Patients Michael J. Blaha MD MPH Presented by: Michael J. Blaha July 24, 2017 1 Talk Outline 1. Coronary artery

More information

Dr Chris Ellis. Consultant Cardiologist Auckland City Hospital Auckland. 11:30-12:00 ECGs for Nurses, and The Basics of CT Heart Scanning

Dr Chris Ellis. Consultant Cardiologist Auckland City Hospital Auckland. 11:30-12:00 ECGs for Nurses, and The Basics of CT Heart Scanning Dr Chris Ellis Consultant Cardiologist Auckland City Hospital Auckland 11:30-12:00 ECGs for Nurses, and The Basics of CT Heart Scanning ECGs for Nurses, and the Basics of CT Heart Scanning Dr Chris Ellis

More information

The International SHAPE Accreditation and Early Detection Program Report

The International SHAPE Accreditation and Early Detection Program Report The International SHAPE Accreditation and Early Detection Program 2012-2014 Report Jeffrey Fine MS, PhD Introduction The implementation of a guideline based early detection program using coronary calcium

More information

VALVULO-METABOLIC RISK IN AORTIC STENOSIS

VALVULO-METABOLIC RISK IN AORTIC STENOSIS January 2008 (Vol. 1, Issue 1, pages 21-25) VALVULO-METABOLIC RISK IN AORTIC STENOSIS By Philippe Pibarot, DVM, PhD, FACC, FAHA Groupe de Recherche en Valvulopathies (GRV), Hôpital Laval Research Centre

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Computed Tomography to Detect Coronary Artery Calcification File Name: computed_tomography_to_detect_coronary_artery_calcification Origination: 3/1994 Last CAP Review 10/2017 Next

More information

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging Daniel S. Berman, MD Director, Cardiac Imaging Cedars-Sinai Heart Institute Professor of Medicine and Imaging Cedars-Sinai

More information

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Paul Mahoney, MD Sentara Cardiology Specialists Lipid Management in Cardiovascular Disease

More information

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary 2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth

More information

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease 21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease Noninvasive Evaluation of Coronary Artery Disease: Anatomical, Functional, Clinical May 5, 2018 Mark Hansen MD FRCPC Cardiologist,

More information

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients Optimal testing for coronary artery disease in symptomatic and asymptomatic patients Alexandre C Ferreira, MD Clinical Chief of Cardiology Jackson Health System Director, Interventional Cardiology Training

More information

Calcium Scoring and Cardiac CT

Calcium Scoring and Cardiac CT Calcium Scoring and Cardiac CT John C. Finley, MD, FACC, FASE Medical Director, CT Department; Alaska Heart and Vascular Institute February 9, 2018 1. Calcium Scoring 2. CT Coronary Angiography 3. Use

More information

Colin Edwards Cardiologist Waitemata Health and Auckland Heart Group

Colin Edwards Cardiologist Waitemata Health and Auckland Heart Group Colin Edwards Cardiologist Waitemata Health and Auckland Heart Group June 2015 Disclosures PFIZER LECTURE SERIES Concepts in CV Risk Assessment Framingham Risk Atheroma Imaging Lifetime CV Risk 4 cases

More information

Role of Nonenhanced Multidetector CT Coronary Artery Calcium Testing in Asymptomatic and Symptomatic Individuals 1

Role of Nonenhanced Multidetector CT Coronary Artery Calcium Testing in Asymptomatic and Symptomatic Individuals 1 Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Role of Nonenhanced

More information

MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL

MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL DEFINITION OF A SCREENING TEST TESTING FOR A DISEASE OR CONDITION IN ASYMPTOMATIC PERSONS TO IDENTIFY THE CONDITION BEFORE IT MANIFESTS

More information

MEDICAL POLICY. 02/15/18 CATEGORY: Technology Assessment

MEDICAL POLICY. 02/15/18 CATEGORY: Technology Assessment MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Familial hypercholesterolaemia in children and adolescents

Familial hypercholesterolaemia in children and adolescents Familial hypercholesterolaemia in children and adolescents Rationale and recommendations for early identification and treatment European Atherosclerosis Society Consensus Panel Slide deck adapted from:

More information

Justification of the use of CT for individual health assessment of asymptomatic people: the Chinese experience

Justification of the use of CT for individual health assessment of asymptomatic people: the Chinese experience Justification of the use of CT for individual health assessment of asymptomatic people: the Chinese experience Liang Wang, MD, PhD Professor, attending radiologist wang6@tjh.tjmu.edu.cn Dept. of Radiology

More information

Calcium scoring Clinical and prognostic value

Calcium scoring Clinical and prognostic value Calcium scoring Clinical and prognostic value Matthijs Oudkerk Professor and Chair of Radiology University Medical Center Groningen, University of Groningen Groningen, The Netherlands Sofia 2011 13 May

More information

CARDIAC IMAGING FOR SUBCLINICAL CAD

CARDIAC IMAGING FOR SUBCLINICAL CAD CARDIAC IMAGING FOR SUBCLINICAL CAD WHY DON'T YOU ADOPT MORE SMART TECHNIQUE? Whal Lee, M.D. Seoul National University Hospital Department of Radiology We are talking about Coronary artery Calcium scoring,

More information

Are We Ready for a Paradigm Shift From Risk Factors to Detection of Subclinical Coronary Atherosclerosis? Lessons From MESA. Khurram Nasir, MD MPH

Are We Ready for a Paradigm Shift From Risk Factors to Detection of Subclinical Coronary Atherosclerosis? Lessons From MESA. Khurram Nasir, MD MPH Are We Ready for a Paradigm Shift From Risk Factors to Detection of Subclinical Coronary Atherosclerosis? Lessons From MESA Khurram Nasir, MD MPH Disclosures No disclosures. Burden of Cardiovascular Disease

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle  holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/28524 holds various files of this Leiden University dissertation Author: Djaberi, Roxana Title: Cardiovascular risk assessment in diabetes Issue Date: 2014-09-04

More information

M Marwan, D Ropers, T Pflederer, W G Daniel, S Achenbach

M Marwan, D Ropers, T Pflederer, W G Daniel, S Achenbach Department of Cardiology, University of Erlangen, Erlangen, Germany Correspondence to: Dr M Marwan, Innere Medizin II, Ulmenweg 18, 91054 Erlangen, Germany; mohamed.marwan@ uk-erlangen.de Accepted 17 November

More information

Risk Assessment for Primary Prevention

Risk Assessment for Primary Prevention Risk Assessment for Primary Prevention AKA Some of You Won t Get a Second Chance to Make a First Impression Alternative Title: The Tension Between Population Medicine and Personalized Medicine Joshua Liberman,

More information

Risk Stratification for CAD for the Primary Care Provider

Risk Stratification for CAD for the Primary Care Provider Risk Stratification for CAD for the Primary Care Provider Shimoli Shah MD Assistant Professor of Medicine Directory, Ambulatory Cardiology Clinic Knight Cardiovascular Institute Oregon Health & Sciences

More information

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for + Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics

More information

ACCF/AHA Expert Consensus Document

ACCF/AHA Expert Consensus Document ACCF/AHA Expert Consensus Document ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring by Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation

More information

The Gender Divide Women, Men and Heart Disease February 2017

The Gender Divide Women, Men and Heart Disease February 2017 The Gender Divide Women, Men and Heart Disease February 2017 Nandita S. Scott, MD FACC Co-Director MGH Heart Center Corrigan Women s Heart Health Program Massachusetts General Hospital Heart Disease For

More information

Imaging in the Evaluation of Coronary Artery Disease and Abdominal Aortic Aneurysm

Imaging in the Evaluation of Coronary Artery Disease and Abdominal Aortic Aneurysm Imaging in the Evaluation of Coronary Artery Disease and Abdominal Aortic Aneurysm Mark J. Sands, MD Vice Chairman, Imaging Institute Clinical Operations and Quality Objectives Review of available radiologic

More information

Heart Disease. Signs and Symptoms

Heart Disease. Signs and Symptoms Heart Disease The term "heart disease" refers to several types of heart conditions. The most common type is coronary artery disease, which can cause heart attack, angina, heart failure, and arrhythmias.

More information

10/8/2015. MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH. None

10/8/2015. MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH. None MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH None 1 Objectives Why the need for change in the guidelines? What is the potential impact of these guidelines? Where do we go from here?

More information

CLINICAL OUTCOME Vs SURROGATE MARKER

CLINICAL OUTCOME Vs SURROGATE MARKER CLINICAL OUTCOME Vs SURROGATE MARKER Statin Real Experience Dr. Mostafa Sherif Senior Medical Manager Pfizer Egypt & Sudan Objective Difference between Clinical outcome and surrogate marker Proper Clinical

More information

Kavitha Yaddanapudi Stony brook University New York

Kavitha Yaddanapudi Stony brook University New York Kavitha Yaddanapudi Stony brook University New York 8 million ER visits a year for chest pain 2-10% have Acute coronary syndrome (ACS) Coronary CTA(CCTA) -safe alternative to standard of care (SOC) and

More information

Noninvasive cardiac imaging refers

Noninvasive cardiac imaging refers CARDIOLOGY PATIENT PAGE Introduction to Noninvasive Cardiac Imaging Ron Blankstein, MD Noninvasive cardiac imaging refers to a combination of methods that can be used to obtain images related to the structure

More information

Diabetes and Heart Disease

Diabetes and Heart Disease Diabetes and Heart Disease Sarah Alexander, MD Assistant Professor of Medicine Division of Cardiology Rush University Medical Center 2/8/2017 Rush is a not-for-profit health care, education and research

More information

Epicardial fat volume as a predictor of coronary vulnerable plaques using cardiac computed tomography in the patients with zero calcium score

Epicardial fat volume as a predictor of coronary vulnerable plaques using cardiac computed tomography in the patients with zero calcium score ESC Congress 2011 Epicardial fat volume as a predictor of coronary vulnerable plaques using cardiac computed tomography in the patients with zero calcium score K. Harada, N. Terada, A. Okada, M. Shigekiyo,

More information

Established Risk Factors for Coronary Heart Disease (CHD)

Established Risk Factors for Coronary Heart Disease (CHD) Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland

More information

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??

More information

Reducing Cardiovascular Risk in Adults. ACC Guidelines for Cholesterol Reduction: NCEP ATP CAOM Winter Seminar

Reducing Cardiovascular Risk in Adults. ACC Guidelines for Cholesterol Reduction: NCEP ATP CAOM Winter Seminar Reducing Cardiovascular Risk in Adults ACC Guidelines for Cholesterol Reduction: NCEP ATP4 2014 CAOM Winter Seminar A Roadmap: Defining the Problem, Implementing Solutions Discuss U.S. Healthcare costs,

More information

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict

More information

Yuan-Chang Liu, 1 Zhonghua Sun, 2 Pei-Kwei Tsay, 3 Tiffany Chan, 4 I-Chang Hsieh, 5 Chun-Chi Chen, 5 Ming-Shien Wen, 5 and Yung-Liang Wan 1

Yuan-Chang Liu, 1 Zhonghua Sun, 2 Pei-Kwei Tsay, 3 Tiffany Chan, 4 I-Chang Hsieh, 5 Chun-Chi Chen, 5 Ming-Shien Wen, 5 and Yung-Liang Wan 1 BioMed Research International Volume 2013, Article ID 472347, 9 pages http://dx.doi.org/10.1155/2013/472347 Research Article Significance of Coronary Calcification for Prediction of Coronary Artery Disease

More information

Beyond Framingham. Prediction of cardiovascular risk. Niels van Pelt Cardiologist, Middlemore Hospital

Beyond Framingham. Prediction of cardiovascular risk. Niels van Pelt Cardiologist, Middlemore Hospital Beyond Framingham Prediction of cardiovascular risk Niels van Pelt Cardiologist, Middlemore Hospital Niels Bohr (Danish Physicist)1885-1962 Prediction is very difficult, especially if it's about the future

More information

CONTRIBUTING FACTORS FOR STROKE:

CONTRIBUTING FACTORS FOR STROKE: CONTRIBUTING FACTORS FOR STROKE: HYPERTENSION AND HYPERCHOLESTEROLEMIA Melissa R. Stephens, MD, FAAFP Associate Professor of Clinical Sciences William Carey University College of Osteopathic Medicine LEARNING

More information

Welcome! To submit questions during the presentation: or Text:

Welcome! To submit questions during the presentation:   or Text: Welcome! To participate in the interactive Q & A please do the following: 1. Download the Socrative Student App 2. Enter Teacher s Room Code: ZD0F3X5Q 3. Select Quiz: Intermountain Cardiac Stress Testing

More information

Key causes of preventable deaths in New Zealand In a population of 10,000 New Zealanders, every year there will be about:

Key causes of preventable deaths in New Zealand In a population of 10,000 New Zealanders, every year there will be about: Preventive care - Chronic Disease Management in primary care: a population perspective Rod Jackson University of Auckland New Zealand (22/11/8) Key causes of preventable deaths in New Zealand In a population

More information

YOUR INFORMATION. Ischemic Heart Disease

YOUR INFORMATION. Ischemic Heart Disease YOUR INFORMATION Ischemic Heart Disease ISCHEMIC HEART DISEASE Your diagnosis You have been given a diagnosis of heart failure, which usually means your heart is working inefficiently. This inefficiency

More information

A CASE REPORT AND LITERATURE REVIEW ON MYOCARDIAL INFARCTION WITH NORMAL CORONARY ARTERIES

A CASE REPORT AND LITERATURE REVIEW ON MYOCARDIAL INFARCTION WITH NORMAL CORONARY ARTERIES A CASE REPORT AND LITERATURE REVIEW ON MYOCARDIAL INFARCTION WITH NORMAL CORONARY ARTERIES Niyamtullah Musalman 1*, Lijun Jin 2 and Farhan Khan 3 *12 Department of Cardiology, Yangtze Medical University

More information